Macro Group Pharmaceuticals (Macro Capital) S.A.E (EGX:MCRO)
1.280
-0.020 (-1.54%)
At close: May 14, 2026
EGX:MCRO Balance Sheet
Financials in millions EGP. Fiscal year is January - December.
Millions EGP. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Equivalents | 176.04 | 62.34 | 75.31 | 186.75 | 60.67 |
Cash & Short-Term Investments | 176.04 | 62.34 | 75.31 | 186.75 | 60.67 |
Cash Growth | 182.39% | -17.22% | -59.67% | 207.81% | 1.07% |
Accounts Receivable | 43.26 | 76.67 | 38.76 | 244.24 | 184.88 |
Receivables | 269.88 | 298.13 | 164.96 | 368.33 | 337.9 |
Inventory | 99.76 | 103.06 | 141.56 | 138.73 | 65.62 |
Prepaid Expenses | - | - | - | - | 0.99 |
Other Current Assets | 81.32 | 50.75 | 41.91 | 38.69 | 10.89 |
Total Current Assets | 627 | 514.27 | 423.74 | 732.51 | 476.07 |
Property, Plant & Equipment | 123.95 | 74.02 | 62.74 | 64.91 | 54.33 |
Goodwill | 25.28 | 25.28 | 25.28 | 46.7 | 46.7 |
Other Intangible Assets | 1.43 | 1.46 | 1.93 | 5.52 | - |
Total Assets | 777.66 | 615.03 | 513.69 | 849.63 | 577.1 |
Accounts Payable | 59.59 | 31.47 | 53.76 | 21.82 | 13.61 |
Accrued Expenses | 88.15 | 120.85 | 81.57 | 79.93 | 47.92 |
Short-Term Debt | 200.76 | 144.16 | 198.29 | 176.77 | 82.99 |
Current Portion of Leases | 13.08 | 17.08 | 4.99 | 7.24 | 3.56 |
Current Income Taxes Payable | 1.04 | 1.15 | 0.29 | 51.88 | 42.24 |
Other Current Liabilities | 100.59 | 67.14 | 55.14 | 28.41 | 15.71 |
Total Current Liabilities | 463.22 | 381.86 | 394.04 | 366.06 | 206.03 |
Long-Term Debt | 86.03 | 138.77 | - | - | - |
Long-Term Leases | 33.55 | 16.3 | 22.9 | 20.63 | 11.26 |
Long-Term Deferred Tax Liabilities | 0.94 | - | 2.42 | - | 1.88 |
Total Liabilities | 583.74 | 536.93 | 419.36 | 386.69 | 219.17 |
Common Stock | 114.04 | 114.04 | 114.04 | 115.47 | 115.47 |
Retained Earnings | 74.72 | -41.01 | 5.25 | 367.33 | 237.5 |
Treasury Stock | - | - | -29.97 | - | - |
Comprehensive Income & Other | 4.89 | 4.89 | 4.89 | -19.97 | 4.89 |
Total Common Equity | 193.66 | 77.93 | 94.21 | 462.83 | 357.86 |
Minority Interest | 0.26 | 0.17 | 0.12 | 0.11 | 0.06 |
Shareholders' Equity | 193.92 | 78.1 | 94.33 | 462.94 | 357.93 |
Total Liabilities & Equity | 777.66 | 615.03 | 513.69 | 849.63 | 577.1 |
Total Debt | 333.43 | 316.32 | 226.18 | 204.65 | 97.81 |
Net Cash (Debt) | -157.39 | -253.98 | -150.87 | -17.89 | -37.14 |
Net Cash Per Share | -0.28 | -0.45 | -0.27 | -0.03 | -0.06 |
Filing Date Shares Outstanding | 570.21 | 562.11 | 563.05 | 570.21 | 577.36 |
Total Common Shares Outstanding | 570.21 | 562.11 | 563.05 | 570.21 | 577.36 |
Working Capital | 163.78 | 132.42 | 29.7 | 366.44 | 270.04 |
Book Value Per Share | 0.34 | 0.14 | 0.17 | 0.81 | 0.62 |
Tangible Book Value | 166.95 | 51.19 | 67 | 410.61 | 311.16 |
Tangible Book Value Per Share | 0.29 | 0.09 | 0.12 | 0.72 | 0.54 |
Land | 3.52 | 3.52 | 3.52 | 3.52 | 3.52 |
Buildings | 26.2 | 16.91 | 16.91 | 16.37 | 16.37 |
Machinery | 88.91 | 57.02 | 45.7 | 39.87 | 34.57 |
Construction In Progress | - | - | - | - | 2.73 |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.